David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
Cognex
CGNX
$9.85B
| $496K | ﹤0.01% |
9,000
| – | – |
|
2877
PUT
Quest Diagnostics
DGX
$26.9B
| $496K | ﹤0.01% |
+5,300
| New | +$563K |
|
|
BKCC
2878
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $496K | ﹤0.01% |
+66,149
| New | +$488K |
|
|
DO
2879
CALL
DELISTED
Diamond Offshore Drilling
DO
| $496K | ﹤0.01% |
34,200
-8,700
| -20% | -$105K |
|
|
LKSD
2880
CALL
DELISTED
LSC Communications, Inc.
LKSD
| $495K | ﹤0.01% |
30,000
| – | – |
|
2881
PUT
Mastercard
MA
$525B
| $494K | ﹤0.01% |
+3,500
| New | +$463K |
|
2882
Peoples Bancorp
PEBO
$1.43B
| $492K | ﹤0.01% |
14,662
-275
| -2% | -$8.72K |
|
|
RDC
2883
DELISTED
Rowan Companies Plc
RDC
| $492K | ﹤0.01% |
38,264
-540,115
| -93% | -$5.79M |
|
2884
Enova International
ENVA
$6.17B
| $490K | ﹤0.01% |
36,427
-16,217
| -31% | -$220K |
|
2885
PUT
DexCom
DXCM
$34.4B
| $489K | ﹤0.01% |
+40,000
| New | +$707K |
|
2886
NOV
NOV
$7.04B
| $489K | ﹤0.01% |
13,690
-2,787
| -17% | -$91K |
|
2887
Weis Markets
WMK
$1.76B
| $489K | ﹤0.01% |
+11,249
| New | +$511K |
|
|
HTB
2888
HomeTrust Bancshares
HTB
$776M
| $489K | ﹤0.01% |
19,066
+2,069
| +12% | +$49.4K |
|
|
PAY
2889
PUT
DELISTED
Verifone Systems Inc
PAY
| $489K | ﹤0.01% |
24,100
-112,000
| -82% | -$2.19M |
|
|
HAPN
2890
CALL
Happen Inc
HAPN
$2.11B
| $487K | ﹤0.01% |
16,000
| – | – |
|
2891
Deluxe
DLX
$1.1B
| $484K | ﹤0.01% |
6,635
-35,673
| -84% | -$2.49M |
|
|
SRCI
2892
CALL
DELISTED
SRC Energy Inc
SRCI
| $484K | ﹤0.01% |
+50,000
| New | +$395K |
|
2893
Helen of Troy
HELE
$666M
| $483K | ﹤0.01% |
4,982
-6,995
| -58% | -$673K |
|
|
AUD
2894
DELISTED
Audacy, Inc.
AUD
| $482K | ﹤0.01% |
42,074
+26,349
| +168% | +$269K |
|
|
PX
2895
DELISTED
Praxair Inc
PX
| $482K | ﹤0.01% |
3,451
+325
| +10% | +$43.3K |
|
2896
CALL
Brighthouse Financial
BHF
$2.98B
| $480K | ﹤0.01% |
+7,893
| New | +$450K |
|
2897
CEVA Inc
CEVA
$751M
| $480K | ﹤0.01% |
11,214
+2,691
| +32% | +$116K |
|
2898
CALL
Capri Holdings
CPRI
$1.55B
| $479K | ﹤0.01% |
10,000
| – | – |
|
|
DMC
2899
Del Monte Corp
DMC
$1.51B
| $479K | ﹤0.01% |
10,545
-13,318
| -56% | -$647K |
|
|
ADMS
2900
DELISTED
Adamas Pharmaceuticals
ADMS
| $477K | ﹤0.01% |
+22,526
| New | +$413K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.